nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PLA2G1B—atherosclerosis	0.54	0.887	CbGaD
Betamethasone—PTGS2—atherosclerosis	0.0692	0.114	CbGaD
Betamethasone—ABCB1—Ezetimibe—atherosclerosis	0.0276	0.152	CbGbCtD
Betamethasone—ABCB1—Simvastatin—atherosclerosis	0.0256	0.141	CbGbCtD
Betamethasone—ABCB1—Pravastatin—atherosclerosis	0.0251	0.138	CbGbCtD
Betamethasone—ABCB1—Lovastatin—atherosclerosis	0.0251	0.138	CbGbCtD
Betamethasone—CYP3A4—Ezetimibe—atherosclerosis	0.0165	0.0909	CbGbCtD
Betamethasone—CYP3A4—Rosuvastatin—atherosclerosis	0.0165	0.0909	CbGbCtD
Betamethasone—CYP3A4—Simvastatin—atherosclerosis	0.0154	0.0845	CbGbCtD
Betamethasone—CYP3A4—Lovastatin—atherosclerosis	0.015	0.0827	CbGbCtD
Betamethasone—CYP3A4—Pravastatin—atherosclerosis	0.015	0.0827	CbGbCtD
Betamethasone—PLA2G1B—blood vessel—atherosclerosis	0.00335	0.121	CbGeAlD
Betamethasone—PGR—artery—atherosclerosis	0.00198	0.0712	CbGeAlD
Betamethasone—PTGS2—leg—atherosclerosis	0.0018	0.065	CbGeAlD
Betamethasone—PLA2G1B—connective tissue—atherosclerosis	0.00172	0.0618	CbGeAlD
Betamethasone—PTGS2—hindlimb—atherosclerosis	0.00161	0.058	CbGeAlD
Betamethasone—PGR—blood vessel—atherosclerosis	0.00154	0.0555	CbGeAlD
Betamethasone—PLA2G1B—cardiovascular system—atherosclerosis	0.00149	0.0538	CbGeAlD
Betamethasone—PTGS2—appendage—atherosclerosis	0.00138	0.0498	CbGeAlD
Betamethasone—PTGS2—artery—atherosclerosis	0.000988	0.0356	CbGeAlD
Betamethasone—Myopathy—Niacin—atherosclerosis	0.000857	0.0086	CcSEcCtD
Betamethasone—NR3C2—connective tissue—atherosclerosis	0.00085	0.0306	CbGeAlD
Betamethasone—Hepatomegaly—Niacin—atherosclerosis	0.000849	0.00852	CcSEcCtD
Betamethasone—Myopathy—Pravastatin—atherosclerosis	0.000844	0.00847	CcSEcCtD
Betamethasone—PTGS2—endothelium—atherosclerosis	0.000834	0.03	CbGeAlD
Betamethasone—Glaucoma—Niacin—atherosclerosis	0.000798	0.00801	CcSEcCtD
Betamethasone—PGR—connective tissue—atherosclerosis	0.00079	0.0284	CbGeAlD
Betamethasone—PTGS2—blood vessel—atherosclerosis	0.000769	0.0277	CbGeAlD
Betamethasone—Necrosis—Niacin—atherosclerosis	0.000766	0.00769	CcSEcCtD
Betamethasone—Tingling sensation—Niacin—atherosclerosis	0.000748	0.00751	CcSEcCtD
Betamethasone—NR3C2—cardiovascular system—atherosclerosis	0.000739	0.0266	CbGeAlD
Betamethasone—Cataract—Lovastatin—atherosclerosis	0.000735	0.00738	CcSEcCtD
Betamethasone—Vasculitis—Lovastatin—atherosclerosis	0.000717	0.0072	CcSEcCtD
Betamethasone—CYP19A1—connective tissue—atherosclerosis	0.000711	0.0256	CbGeAlD
Betamethasone—Vasculitis—Ezetimibe—atherosclerosis	0.000703	0.00706	CcSEcCtD
Betamethasone—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.000689	0.00692	CcSEcCtD
Betamethasone—Cataract—Simvastatin—atherosclerosis	0.000688	0.0069	CcSEcCtD
Betamethasone—PGR—cardiovascular system—atherosclerosis	0.000687	0.0247	CbGeAlD
Betamethasone—Vasculitis—Simvastatin—atherosclerosis	0.000671	0.00673	CcSEcCtD
Betamethasone—Injury—Rosuvastatin—atherosclerosis	0.000652	0.00655	CcSEcCtD
Betamethasone—NR3C2—adipose tissue—atherosclerosis	0.000652	0.0235	CbGeAlD
Betamethasone—Cataract—Pravastatin—atherosclerosis	0.000622	0.00624	CcSEcCtD
Betamethasone—Vasculitis—Pravastatin—atherosclerosis	0.000606	0.00609	CcSEcCtD
Betamethasone—PGR—adipose tissue—atherosclerosis	0.000606	0.0218	CbGeAlD
Betamethasone—Dermatitis contact—Niacin—atherosclerosis	0.000594	0.00596	CcSEcCtD
Betamethasone—Skin exfoliation—Niacin—atherosclerosis	0.000574	0.00576	CcSEcCtD
Betamethasone—Fluid retention—Niacin—atherosclerosis	0.000571	0.00573	CcSEcCtD
Betamethasone—Neuropathy—Pravastatin—atherosclerosis	0.000556	0.00558	CcSEcCtD
Betamethasone—Injury—Lovastatin—atherosclerosis	0.000553	0.00555	CcSEcCtD
Betamethasone—Oesophagitis—Niacin—atherosclerosis	0.000549	0.00551	CcSEcCtD
Betamethasone—Diabetes mellitus—Simvastatin—atherosclerosis	0.000546	0.00548	CcSEcCtD
Betamethasone—CYP19A1—adipose tissue—atherosclerosis	0.000545	0.0196	CbGeAlD
Betamethasone—Muscular weakness—Rosuvastatin—atherosclerosis	0.000529	0.00531	CcSEcCtD
Betamethasone—Diabetes mellitus—Niacin—atherosclerosis	0.000502	0.00504	CcSEcCtD
Betamethasone—ABCB1—blood vessel—atherosclerosis	0.000476	0.0171	CbGeAlD
Betamethasone—Injury—Pravastatin—atherosclerosis	0.000467	0.00469	CcSEcCtD
Betamethasone—NR3C2—liver—atherosclerosis	0.000457	0.0165	CbGeAlD
Betamethasone—Dermatitis bullous—Niacin—atherosclerosis	0.000457	0.00458	CcSEcCtD
Betamethasone—NR3C1—connective tissue—atherosclerosis	0.000456	0.0164	CbGeAlD
Betamethasone—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000453	0.00455	CcSEcCtD
Betamethasone—Muscular weakness—Ezetimibe—atherosclerosis	0.00044	0.00441	CcSEcCtD
Betamethasone—Migraine—Niacin—atherosclerosis	0.00043	0.00431	CcSEcCtD
Betamethasone—Affect lability—Pravastatin—atherosclerosis	0.000423	0.00424	CcSEcCtD
Betamethasone—Muscular weakness—Simvastatin—atherosclerosis	0.000419	0.00421	CcSEcCtD
Betamethasone—Mood swings—Pravastatin—atherosclerosis	0.000407	0.00408	CcSEcCtD
Betamethasone—Dry skin—Niacin—atherosclerosis	0.0004	0.00401	CcSEcCtD
Betamethasone—NR3C1—cardiovascular system—atherosclerosis	0.000397	0.0143	CbGeAlD
Betamethasone—PTGS2—connective tissue—atherosclerosis	0.000394	0.0142	CbGeAlD
Betamethasone—Dry skin—Pravastatin—atherosclerosis	0.000394	0.00395	CcSEcCtD
Betamethasone—Muscular weakness—Niacin—atherosclerosis	0.000385	0.00386	CcSEcCtD
Betamethasone—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000384	0.00385	CcSEcCtD
Betamethasone—CYP19A1—liver—atherosclerosis	0.000382	0.0138	CbGeAlD
Betamethasone—Muscular weakness—Pravastatin—atherosclerosis	0.000379	0.0038	CcSEcCtD
Betamethasone—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000376	0.00378	CcSEcCtD
Betamethasone—Arrhythmia—Rosuvastatin—atherosclerosis	0.000371	0.00372	CcSEcCtD
Betamethasone—Sweating increased—Pravastatin—atherosclerosis	0.000362	0.00363	CcSEcCtD
Betamethasone—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000359	0.0036	CcSEcCtD
Betamethasone—NR3C1—adipose tissue—atherosclerosis	0.00035	0.0126	CbGeAlD
Betamethasone—PTGS2—cardiovascular system—atherosclerosis	0.000343	0.0124	CbGeAlD
Betamethasone—Weight increased—Pravastatin—atherosclerosis	0.000338	0.00339	CcSEcCtD
Betamethasone—Weight decreased—Pravastatin—atherosclerosis	0.000336	0.00337	CcSEcCtD
Betamethasone—Angioedema—Rosuvastatin—atherosclerosis	0.00033	0.00331	CcSEcCtD
Betamethasone—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000326	0.00328	CcSEcCtD
Betamethasone—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000325	0.00326	CcSEcCtD
Betamethasone—Myocardial infarction—Pravastatin—atherosclerosis	0.000325	0.00326	CcSEcCtD
Betamethasone—Dexamethasone—PLA2G1B—atherosclerosis	0.000317	0.381	CrCbGaD
Betamethasone—Angiopathy—Ezetimibe—atherosclerosis	0.000313	0.00314	CcSEcCtD
Betamethasone—Alopecia—Lovastatin—atherosclerosis	0.000311	0.00312	CcSEcCtD
Betamethasone—Myalgia—Rosuvastatin—atherosclerosis	0.000307	0.00308	CcSEcCtD
Betamethasone—Alopecia—Ezetimibe—atherosclerosis	0.000305	0.00306	CcSEcCtD
Betamethasone—Haemoglobin—Niacin—atherosclerosis	0.000303	0.00305	CcSEcCtD
Betamethasone—PTGS2—adipose tissue—atherosclerosis	0.000303	0.0109	CbGeAlD
Betamethasone—Haemorrhage—Niacin—atherosclerosis	0.000302	0.00303	CcSEcCtD
Betamethasone—Erythema—Ezetimibe—atherosclerosis	0.0003	0.00301	CcSEcCtD
Betamethasone—Infection—Rosuvastatin—atherosclerosis	0.000293	0.00294	CcSEcCtD
Betamethasone—Visual impairment—Niacin—atherosclerosis	0.000291	0.00292	CcSEcCtD
Betamethasone—Alopecia—Simvastatin—atherosclerosis	0.000291	0.00292	CcSEcCtD
Betamethasone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000289	0.0029	CcSEcCtD
Betamethasone—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000289	0.0029	CcSEcCtD
Betamethasone—Visual impairment—Pravastatin—atherosclerosis	0.000286	0.00287	CcSEcCtD
Betamethasone—Erythema—Simvastatin—atherosclerosis	0.000286	0.00287	CcSEcCtD
Betamethasone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000284	0.00285	CcSEcCtD
Betamethasone—Eye disorder—Niacin—atherosclerosis	0.000282	0.00283	CcSEcCtD
Betamethasone—Angioedema—Lovastatin—atherosclerosis	0.00028	0.00281	CcSEcCtD
Betamethasone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000278	0.00279	CcSEcCtD
Betamethasone—Malaise—Lovastatin—atherosclerosis	0.000276	0.00277	CcSEcCtD
Betamethasone—Vertigo—Lovastatin—atherosclerosis	0.000275	0.00276	CcSEcCtD
Betamethasone—Angioedema—Ezetimibe—atherosclerosis	0.000274	0.00275	CcSEcCtD
Betamethasone—Angiopathy—Niacin—atherosclerosis	0.000274	0.00275	CcSEcCtD
Betamethasone—Malaise—Ezetimibe—atherosclerosis	0.000271	0.00272	CcSEcCtD
Betamethasone—Arrhythmia—Niacin—atherosclerosis	0.00027	0.00271	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000268	0.00269	CcSEcCtD
Betamethasone—Alopecia—Niacin—atherosclerosis	0.000267	0.00268	CcSEcCtD
Betamethasone—Insomnia—Rosuvastatin—atherosclerosis	0.000267	0.00267	CcSEcCtD
Betamethasone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000266	0.00267	CcSEcCtD
Betamethasone—Arrhythmia—Pravastatin—atherosclerosis	0.000266	0.00266	CcSEcCtD
Betamethasone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000265	0.00266	CcSEcCtD
Betamethasone—Erythema—Niacin—atherosclerosis	0.000263	0.00264	CcSEcCtD
Betamethasone—Alopecia—Pravastatin—atherosclerosis	0.000263	0.00264	CcSEcCtD
Betamethasone—Angioedema—Simvastatin—atherosclerosis	0.000262	0.00262	CcSEcCtD
Betamethasone—Myalgia—Lovastatin—atherosclerosis	0.000261	0.00261	CcSEcCtD
Betamethasone—Anxiety—Lovastatin—atherosclerosis	0.00026	0.00261	CcSEcCtD
Betamethasone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000259	0.0026	CcSEcCtD
Betamethasone—Hypertension—Ezetimibe—atherosclerosis	0.000259	0.0026	CcSEcCtD
Betamethasone—Malaise—Simvastatin—atherosclerosis	0.000258	0.00259	CcSEcCtD
Betamethasone—Discomfort—Lovastatin—atherosclerosis	0.000257	0.00258	CcSEcCtD
Betamethasone—Vertigo—Simvastatin—atherosclerosis	0.000257	0.00258	CcSEcCtD
Betamethasone—Myalgia—Ezetimibe—atherosclerosis	0.000256	0.00256	CcSEcCtD
Betamethasone—Discomfort—Ezetimibe—atherosclerosis	0.000252	0.00253	CcSEcCtD
Betamethasone—Pain—Rosuvastatin—atherosclerosis	0.000252	0.00253	CcSEcCtD
Betamethasone—Anaphylactic shock—Lovastatin—atherosclerosis	0.00025	0.00251	CcSEcCtD
Betamethasone—Infection—Lovastatin—atherosclerosis	0.000248	0.00249	CcSEcCtD
Betamethasone—NR3C1—liver—atherosclerosis	0.000245	0.00883	CbGeAlD
Betamethasone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000245	0.00246	CcSEcCtD
Betamethasone—Thrombocytopenia—Lovastatin—atherosclerosis	0.000245	0.00245	CcSEcCtD
Betamethasone—Myalgia—Simvastatin—atherosclerosis	0.000244	0.00245	CcSEcCtD
Betamethasone—Infection—Ezetimibe—atherosclerosis	0.000243	0.00244	CcSEcCtD
Betamethasone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000243	0.00244	CcSEcCtD
Betamethasone—Anxiety—Simvastatin—atherosclerosis	0.000243	0.00244	CcSEcCtD
Betamethasone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000241	0.00242	CcSEcCtD
Betamethasone—Discomfort—Simvastatin—atherosclerosis	0.000241	0.00242	CcSEcCtD
Betamethasone—Nervous system disorder—Ezetimibe—atherosclerosis	0.00024	0.00241	CcSEcCtD
Betamethasone—Angioedema—Niacin—atherosclerosis	0.00024	0.00241	CcSEcCtD
Betamethasone—Ill-defined disorder—Pravastatin—atherosclerosis	0.00024	0.00241	CcSEcCtD
Betamethasone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00024	0.00241	CcSEcCtD
Betamethasone—Anorexia—Lovastatin—atherosclerosis	0.000238	0.00239	CcSEcCtD
Betamethasone—Angioedema—Pravastatin—atherosclerosis	0.000236	0.00237	CcSEcCtD
Betamethasone—Vertigo—Niacin—atherosclerosis	0.000236	0.00237	CcSEcCtD
Betamethasone—Syncope—Niacin—atherosclerosis	0.000236	0.00237	CcSEcCtD
Betamethasone—Urticaria—Rosuvastatin—atherosclerosis	0.000234	0.00235	CcSEcCtD
Betamethasone—Oedema—Simvastatin—atherosclerosis	0.000234	0.00234	CcSEcCtD
Betamethasone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000234	0.00234	CcSEcCtD
Betamethasone—Malaise—Pravastatin—atherosclerosis	0.000233	0.00234	CcSEcCtD
Betamethasone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000233	0.00234	CcSEcCtD
Betamethasone—Vertigo—Pravastatin—atherosclerosis	0.000232	0.00233	CcSEcCtD
Betamethasone—Infection—Simvastatin—atherosclerosis	0.000232	0.00233	CcSEcCtD
Betamethasone—Loss of consciousness—Niacin—atherosclerosis	0.000231	0.00232	CcSEcCtD
Betamethasone—Thrombocytopenia—Simvastatin—atherosclerosis	0.000229	0.0023	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000228	0.00228	CcSEcCtD
Betamethasone—Insomnia—Lovastatin—atherosclerosis	0.000226	0.00227	CcSEcCtD
Betamethasone—Paraesthesia—Lovastatin—atherosclerosis	0.000224	0.00225	CcSEcCtD
Betamethasone—Myalgia—Niacin—atherosclerosis	0.000224	0.00225	CcSEcCtD
Betamethasone—Hypertension—Pravastatin—atherosclerosis	0.000223	0.00224	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000223	0.00224	CcSEcCtD
Betamethasone—Anorexia—Simvastatin—atherosclerosis	0.000223	0.00223	CcSEcCtD
Betamethasone—Insomnia—Ezetimibe—atherosclerosis	0.000222	0.00222	CcSEcCtD
Betamethasone—Myalgia—Pravastatin—atherosclerosis	0.00022	0.00221	CcSEcCtD
Betamethasone—Paraesthesia—Ezetimibe—atherosclerosis	0.00022	0.00221	CcSEcCtD
Betamethasone—Dyspepsia—Lovastatin—atherosclerosis	0.00022	0.00221	CcSEcCtD
Betamethasone—Anxiety—Pravastatin—atherosclerosis	0.00022	0.0022	CcSEcCtD
Betamethasone—Discomfort—Pravastatin—atherosclerosis	0.000218	0.00218	CcSEcCtD
Betamethasone—Decreased appetite—Lovastatin—atherosclerosis	0.000217	0.00218	CcSEcCtD
Betamethasone—Dyspepsia—Ezetimibe—atherosclerosis	0.000216	0.00216	CcSEcCtD
Betamethasone—Fatigue—Lovastatin—atherosclerosis	0.000215	0.00216	CcSEcCtD
Betamethasone—Anaphylactic shock—Niacin—atherosclerosis	0.000214	0.00215	CcSEcCtD
Betamethasone—Oedema—Niacin—atherosclerosis	0.000214	0.00215	CcSEcCtD
Betamethasone—Pain—Lovastatin—atherosclerosis	0.000214	0.00214	CcSEcCtD
Betamethasone—Decreased appetite—Ezetimibe—atherosclerosis	0.000213	0.00214	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000213	0.00214	CcSEcCtD
Betamethasone—ABCB1—cardiovascular system—atherosclerosis	0.000212	0.00764	CbGeAlD
Betamethasone—PTGS2—liver—atherosclerosis	0.000212	0.00764	CbGeAlD
Betamethasone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000211	0.00212	CcSEcCtD
Betamethasone—Asthenia—Rosuvastatin—atherosclerosis	0.000211	0.00212	CcSEcCtD
Betamethasone—Insomnia—Simvastatin—atherosclerosis	0.000211	0.00212	CcSEcCtD
Betamethasone—Oedema—Pravastatin—atherosclerosis	0.000211	0.00212	CcSEcCtD
Betamethasone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000211	0.00212	CcSEcCtD
Betamethasone—Fatigue—Ezetimibe—atherosclerosis	0.000211	0.00212	CcSEcCtD
Betamethasone—Shock—Niacin—atherosclerosis	0.000211	0.00212	CcSEcCtD
Betamethasone—Infection—Pravastatin—atherosclerosis	0.00021	0.00211	CcSEcCtD
Betamethasone—Paraesthesia—Simvastatin—atherosclerosis	0.00021	0.00211	CcSEcCtD
Betamethasone—Pain—Ezetimibe—atherosclerosis	0.000209	0.0021	CcSEcCtD
Betamethasone—Tachycardia—Niacin—atherosclerosis	0.000209	0.0021	CcSEcCtD
Betamethasone—Pruritus—Rosuvastatin—atherosclerosis	0.000208	0.00209	CcSEcCtD
Betamethasone—Hyperhidrosis—Niacin—atherosclerosis	0.000207	0.00208	CcSEcCtD
Betamethasone—Thrombocytopenia—Pravastatin—atherosclerosis	0.000207	0.00208	CcSEcCtD
Betamethasone—Feeling abnormal—Lovastatin—atherosclerosis	0.000206	0.00207	CcSEcCtD
Betamethasone—Dyspepsia—Simvastatin—atherosclerosis	0.000206	0.00206	CcSEcCtD
Betamethasone—Anorexia—Niacin—atherosclerosis	0.000204	0.00205	CcSEcCtD
Betamethasone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000204	0.00205	CcSEcCtD
Betamethasone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000204	0.00205	CcSEcCtD
Betamethasone—Decreased appetite—Simvastatin—atherosclerosis	0.000203	0.00204	CcSEcCtD
Betamethasone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000202	0.00203	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000202	0.00202	CcSEcCtD
Betamethasone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000202	0.00202	CcSEcCtD
Betamethasone—Fatigue—Simvastatin—atherosclerosis	0.000201	0.00202	CcSEcCtD
Betamethasone—Anorexia—Pravastatin—atherosclerosis	0.000201	0.00202	CcSEcCtD
Betamethasone—Hypotension—Niacin—atherosclerosis	0.0002	0.00201	CcSEcCtD
Betamethasone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.0002	0.00201	CcSEcCtD
Betamethasone—Pain—Simvastatin—atherosclerosis	0.0002	0.002	CcSEcCtD
Betamethasone—Urticaria—Lovastatin—atherosclerosis	0.000198	0.00199	CcSEcCtD
Betamethasone—Body temperature increased—Lovastatin—atherosclerosis	0.000197	0.00198	CcSEcCtD
Betamethasone—Abdominal pain—Lovastatin—atherosclerosis	0.000197	0.00198	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000195	0.00196	CcSEcCtD
Betamethasone—Dizziness—Rosuvastatin—atherosclerosis	0.000195	0.00196	CcSEcCtD
Betamethasone—Urticaria—Ezetimibe—atherosclerosis	0.000195	0.00195	CcSEcCtD
Betamethasone—Insomnia—Niacin—atherosclerosis	0.000194	0.00195	CcSEcCtD
Betamethasone—Abdominal pain—Ezetimibe—atherosclerosis	0.000194	0.00194	CcSEcCtD
Betamethasone—Body temperature increased—Ezetimibe—atherosclerosis	0.000194	0.00194	CcSEcCtD
Betamethasone—Paraesthesia—Niacin—atherosclerosis	0.000193	0.00193	CcSEcCtD
Betamethasone—Feeling abnormal—Simvastatin—atherosclerosis	0.000192	0.00193	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000192	0.00193	CcSEcCtD
Betamethasone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000191	0.00192	CcSEcCtD
Betamethasone—Insomnia—Pravastatin—atherosclerosis	0.000191	0.00192	CcSEcCtD
Betamethasone—Paraesthesia—Pravastatin—atherosclerosis	0.00019	0.0019	CcSEcCtD
Betamethasone—Dyspepsia—Niacin—atherosclerosis	0.000189	0.00189	CcSEcCtD
Betamethasone—ABCB1—adipose tissue—atherosclerosis	0.000187	0.00674	CbGeAlD
Betamethasone—Decreased appetite—Niacin—atherosclerosis	0.000186	0.00187	CcSEcCtD
Betamethasone—Dyspepsia—Pravastatin—atherosclerosis	0.000186	0.00187	CcSEcCtD
Betamethasone—Rash—Rosuvastatin—atherosclerosis	0.000186	0.00186	CcSEcCtD
Betamethasone—Dermatitis—Rosuvastatin—atherosclerosis	0.000186	0.00186	CcSEcCtD
Betamethasone—Urticaria—Simvastatin—atherosclerosis	0.000186	0.00186	CcSEcCtD
Betamethasone—CYP3A4—liver—atherosclerosis	0.000185	0.00668	CbGeAlD
Betamethasone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000185	0.00186	CcSEcCtD
Betamethasone—Abdominal pain—Simvastatin—atherosclerosis	0.000185	0.00185	CcSEcCtD
Betamethasone—Body temperature increased—Simvastatin—atherosclerosis	0.000185	0.00185	CcSEcCtD
Betamethasone—Headache—Rosuvastatin—atherosclerosis	0.000185	0.00185	CcSEcCtD
Betamethasone—Decreased appetite—Pravastatin—atherosclerosis	0.000184	0.00184	CcSEcCtD
Betamethasone—Pain—Niacin—atherosclerosis	0.000183	0.00184	CcSEcCtD
Betamethasone—Fatigue—Pravastatin—atherosclerosis	0.000182	0.00183	CcSEcCtD
Betamethasone—Pain—Pravastatin—atherosclerosis	0.000181	0.00181	CcSEcCtD
Betamethasone—Fluoxymesterone—ESR1—atherosclerosis	0.000179	0.215	CrCbGaD
Betamethasone—Asthenia—Lovastatin—atherosclerosis	0.000179	0.0018	CcSEcCtD
Betamethasone—Pruritus—Lovastatin—atherosclerosis	0.000177	0.00177	CcSEcCtD
Betamethasone—Asthenia—Ezetimibe—atherosclerosis	0.000176	0.00176	CcSEcCtD
Betamethasone—Gastrointestinal pain—Niacin—atherosclerosis	0.000175	0.00176	CcSEcCtD
Betamethasone—Nausea—Rosuvastatin—atherosclerosis	0.000175	0.00176	CcSEcCtD
Betamethasone—Feeling abnormal—Pravastatin—atherosclerosis	0.000174	0.00175	CcSEcCtD
Betamethasone—Pruritus—Ezetimibe—atherosclerosis	0.000173	0.00174	CcSEcCtD
Betamethasone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000173	0.00173	CcSEcCtD
Betamethasone—Diarrhoea—Lovastatin—atherosclerosis	0.000171	0.00171	CcSEcCtD
Betamethasone—Urticaria—Niacin—atherosclerosis	0.00017	0.00171	CcSEcCtD
Betamethasone—Abdominal pain—Niacin—atherosclerosis	0.00017	0.0017	CcSEcCtD
Betamethasone—Body temperature increased—Niacin—atherosclerosis	0.00017	0.0017	CcSEcCtD
Betamethasone—Urticaria—Pravastatin—atherosclerosis	0.000168	0.00168	CcSEcCtD
Betamethasone—Asthenia—Simvastatin—atherosclerosis	0.000168	0.00168	CcSEcCtD
Betamethasone—Diarrhoea—Ezetimibe—atherosclerosis	0.000168	0.00168	CcSEcCtD
Betamethasone—Body temperature increased—Pravastatin—atherosclerosis	0.000167	0.00168	CcSEcCtD
Betamethasone—Abdominal pain—Pravastatin—atherosclerosis	0.000167	0.00168	CcSEcCtD
Betamethasone—Pruritus—Simvastatin—atherosclerosis	0.000165	0.00166	CcSEcCtD
Betamethasone—Dizziness—Lovastatin—atherosclerosis	0.000165	0.00166	CcSEcCtD
Betamethasone—Dizziness—Ezetimibe—atherosclerosis	0.000162	0.00163	CcSEcCtD
Betamethasone—Diarrhoea—Simvastatin—atherosclerosis	0.00016	0.0016	CcSEcCtD
Betamethasone—Vomiting—Lovastatin—atherosclerosis	0.000159	0.00159	CcSEcCtD
Betamethasone—Rash—Lovastatin—atherosclerosis	0.000157	0.00158	CcSEcCtD
Betamethasone—Dermatitis—Lovastatin—atherosclerosis	0.000157	0.00158	CcSEcCtD
Betamethasone—Headache—Lovastatin—atherosclerosis	0.000156	0.00157	CcSEcCtD
Betamethasone—Vomiting—Ezetimibe—atherosclerosis	0.000156	0.00156	CcSEcCtD
Betamethasone—Dizziness—Simvastatin—atherosclerosis	0.000154	0.00155	CcSEcCtD
Betamethasone—Rash—Ezetimibe—atherosclerosis	0.000154	0.00155	CcSEcCtD
Betamethasone—Dermatitis—Ezetimibe—atherosclerosis	0.000154	0.00155	CcSEcCtD
Betamethasone—Asthenia—Niacin—atherosclerosis	0.000154	0.00154	CcSEcCtD
Betamethasone—Headache—Ezetimibe—atherosclerosis	0.000153	0.00154	CcSEcCtD
Betamethasone—Pruritus—Niacin—atherosclerosis	0.000152	0.00152	CcSEcCtD
Betamethasone—Asthenia—Pravastatin—atherosclerosis	0.000152	0.00152	CcSEcCtD
Betamethasone—Pruritus—Pravastatin—atherosclerosis	0.000149	0.0015	CcSEcCtD
Betamethasone—Vomiting—Simvastatin—atherosclerosis	0.000149	0.00149	CcSEcCtD
Betamethasone—Nausea—Lovastatin—atherosclerosis	0.000148	0.00149	CcSEcCtD
Betamethasone—Rash—Simvastatin—atherosclerosis	0.000147	0.00148	CcSEcCtD
Betamethasone—Dermatitis—Simvastatin—atherosclerosis	0.000147	0.00148	CcSEcCtD
Betamethasone—Diarrhoea—Niacin—atherosclerosis	0.000147	0.00147	CcSEcCtD
Betamethasone—Headache—Simvastatin—atherosclerosis	0.000146	0.00147	CcSEcCtD
Betamethasone—Nausea—Ezetimibe—atherosclerosis	0.000145	0.00146	CcSEcCtD
Betamethasone—Diarrhoea—Pravastatin—atherosclerosis	0.000144	0.00145	CcSEcCtD
Betamethasone—Dizziness—Niacin—atherosclerosis	0.000142	0.00142	CcSEcCtD
Betamethasone—Dexamethasone—NOS2—atherosclerosis	0.000142	0.17	CrCbGaD
Betamethasone—Dizziness—Pravastatin—atherosclerosis	0.00014	0.0014	CcSEcCtD
Betamethasone—Nausea—Simvastatin—atherosclerosis	0.000139	0.00139	CcSEcCtD
Betamethasone—Vomiting—Niacin—atherosclerosis	0.000136	0.00137	CcSEcCtD
Betamethasone—Rash—Niacin—atherosclerosis	0.000135	0.00136	CcSEcCtD
Betamethasone—Dermatitis—Niacin—atherosclerosis	0.000135	0.00136	CcSEcCtD
Betamethasone—Headache—Niacin—atherosclerosis	0.000134	0.00135	CcSEcCtD
Betamethasone—Vomiting—Pravastatin—atherosclerosis	0.000134	0.00135	CcSEcCtD
Betamethasone—Rash—Pravastatin—atherosclerosis	0.000133	0.00134	CcSEcCtD
Betamethasone—Dermatitis—Pravastatin—atherosclerosis	0.000133	0.00134	CcSEcCtD
Betamethasone—Headache—Pravastatin—atherosclerosis	0.000132	0.00133	CcSEcCtD
Betamethasone—ABCB1—liver—atherosclerosis	0.000131	0.00473	CbGeAlD
Betamethasone—Nausea—Niacin—atherosclerosis	0.000127	0.00128	CcSEcCtD
Betamethasone—Nausea—Pravastatin—atherosclerosis	0.000125	0.00126	CcSEcCtD
Betamethasone—Triamcinolone—PTGS2—atherosclerosis	8.53e-05	0.102	CrCbGaD
Betamethasone—Prednisone—ALB—atherosclerosis	6.89e-05	0.0828	CrCbGaD
Betamethasone—Dexamethasone—PTGS2—atherosclerosis	4.06e-05	0.0488	CrCbGaD
Betamethasone—NR3C1—Gene Expression—ESR2—atherosclerosis	1.59e-05	0.000195	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.58e-05	0.000194	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.56e-05	0.000192	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.55e-05	0.000191	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	1.55e-05	0.000191	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOA2—atherosclerosis	1.53e-05	0.000188	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PLA2G2A—atherosclerosis	1.53e-05	0.000188	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALOX15—atherosclerosis	1.53e-05	0.000188	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALOX5AP—atherosclerosis	1.53e-05	0.000188	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PPARG—atherosclerosis	1.52e-05	0.000187	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SOCS3—atherosclerosis	1.52e-05	0.000186	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HMGCR—atherosclerosis	1.52e-05	0.000186	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ABCG5—atherosclerosis	1.51e-05	0.000186	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.51e-05	0.000186	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.49e-05	0.000184	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.48e-05	0.000182	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CST3—atherosclerosis	1.47e-05	0.000181	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP3—atherosclerosis	1.47e-05	0.00018	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MAPK3—atherosclerosis	1.46e-05	0.00018	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—LPA—atherosclerosis	1.46e-05	0.00018	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF2—atherosclerosis	1.46e-05	0.000179	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APOB—atherosclerosis	1.42e-05	0.000174	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—BGN—atherosclerosis	1.42e-05	0.000174	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.41e-05	0.000173	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOA5—atherosclerosis	1.4e-05	0.000172	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NAMPT—atherosclerosis	1.39e-05	0.000171	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EDN1—atherosclerosis	1.39e-05	0.000171	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCL5—atherosclerosis	1.38e-05	0.00017	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOC3—atherosclerosis	1.38e-05	0.000169	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LDLR—atherosclerosis	1.37e-05	0.000168	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SERPINE1—atherosclerosis	1.37e-05	0.000168	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.37e-05	0.000168	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ABCG1—atherosclerosis	1.37e-05	0.000168	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.36e-05	0.000167	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LPL—atherosclerosis	1.35e-05	0.000166	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ABCA1—atherosclerosis	1.35e-05	0.000166	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PLA2G1B—atherosclerosis	1.35e-05	0.000166	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.35e-05	0.000165	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.33e-05	0.000164	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.32e-05	0.000163	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HSPA1B—atherosclerosis	1.32e-05	0.000163	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.32e-05	0.000162	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.32e-05	0.000162	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PRKCG—atherosclerosis	1.31e-05	0.000162	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.31e-05	0.000161	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALOX5—atherosclerosis	1.3e-05	0.00016	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LCAT—atherosclerosis	1.29e-05	0.000158	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—FABP4—atherosclerosis	1.29e-05	0.000158	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SPP1—atherosclerosis	1.28e-05	0.000157	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NCF1—atherosclerosis	1.28e-05	0.000157	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SIRT1—atherosclerosis	1.28e-05	0.000157	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.27e-05	0.000156	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOA4—atherosclerosis	1.26e-05	0.000155	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.24e-05	0.000152	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLTP—atherosclerosis	1.23e-05	0.000151	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.22e-05	0.00015	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CYBA—atherosclerosis	1.2e-05	0.000148	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.2e-05	0.000148	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PDGFB—atherosclerosis	1.19e-05	0.000146	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PARP1—atherosclerosis	1.18e-05	0.000145	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.17e-05	0.000144	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NAMPT—atherosclerosis	1.17e-05	0.000144	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.16e-05	0.000143	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—LIPC—atherosclerosis	1.16e-05	0.000143	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HMOX1—atherosclerosis	1.16e-05	0.000142	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AGT—atherosclerosis	1.16e-05	0.000142	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.16e-05	0.000142	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOC3—atherosclerosis	1.15e-05	0.000142	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—LDLR—atherosclerosis	1.15e-05	0.000141	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.15e-05	0.000141	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APOE—atherosclerosis	1.13e-05	0.000139	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LEP—atherosclerosis	1.13e-05	0.000139	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CAV1—atherosclerosis	1.12e-05	0.000138	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.12e-05	0.000138	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.12e-05	0.000138	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APOA1—atherosclerosis	1.12e-05	0.000138	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CETP—atherosclerosis	1.12e-05	0.000138	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOB—atherosclerosis	1.11e-05	0.000136	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.1e-05	0.000135	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.09e-05	0.000133	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOA2—atherosclerosis	1.09e-05	0.000133	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.09e-05	0.000133	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALOX15—atherosclerosis	1.09e-05	0.000133	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ESR1—atherosclerosis	1.08e-05	0.000133	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTM1—atherosclerosis	1.08e-05	0.000133	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ABCG5—atherosclerosis	1.07e-05	0.000132	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SCARB1—atherosclerosis	1.07e-05	0.000132	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—F2—atherosclerosis	1.07e-05	0.000131	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.07e-05	0.000131	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.07e-05	0.000131	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARA—atherosclerosis	1.06e-05	0.000131	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—LPL—atherosclerosis	1.06e-05	0.00013	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.05e-05	0.000129	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.04e-05	0.000128	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LPA—atherosclerosis	1.04e-05	0.000127	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GPX1—atherosclerosis	1.03e-05	0.000127	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CG—atherosclerosis	1.02e-05	0.000126	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HMGCR—atherosclerosis	1.01e-05	0.000124	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CD36—atherosclerosis	1.01e-05	0.000124	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—BGN—atherosclerosis	1e-05	0.000123	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOA5—atherosclerosis	9.93e-06	0.000122	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—atherosclerosis	9.86e-06	0.000121	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—INS—atherosclerosis	9.68e-06	0.000119	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ESR1—atherosclerosis	9.62e-06	0.000118	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PLA2G1B—atherosclerosis	9.56e-06	0.000117	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MTHFR—atherosclerosis	9.55e-06	0.000117	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCL2—atherosclerosis	9.53e-06	0.000117	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	9.47e-06	0.000116	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1—atherosclerosis	9.37e-06	0.000115	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARA—atherosclerosis	9.37e-06	0.000115	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALOX5—atherosclerosis	9.23e-06	0.000113	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AGT—atherosclerosis	9.07e-06	0.000111	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ABCA1—atherosclerosis	9.03e-06	0.000111	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MAPK3—atherosclerosis	8.9e-06	0.000109	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SERPINE1—atherosclerosis	8.89e-06	0.000109	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOE—atherosclerosis	8.89e-06	0.000109	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	8.88e-06	0.000109	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOB—atherosclerosis	8.86e-06	0.000109	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CAV1—atherosclerosis	8.81e-06	0.000108	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOA1—atherosclerosis	8.79e-06	0.000108	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARG—atherosclerosis	8.78e-06	0.000108	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOS3—atherosclerosis	8.49e-06	0.000104	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LPL—atherosclerosis	8.46e-06	0.000104	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCG1—atherosclerosis	8.42e-06	0.000103	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—atherosclerosis	8.38e-06	0.000103	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NAMPT—atherosclerosis	8.28e-06	0.000102	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LIPC—atherosclerosis	8.23e-06	0.000101	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PRKCG—atherosclerosis	8.22e-06	0.000101	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOC3—atherosclerosis	8.18e-06	0.000101	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LDLR—atherosclerosis	8.13e-06	9.99e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CG—atherosclerosis	8.02e-06	9.86e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CETP—atherosclerosis	7.94e-06	9.76e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—FABP4—atherosclerosis	7.92e-06	9.73e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LCAT—atherosclerosis	7.92e-06	9.73e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SERPINE1—atherosclerosis	7.91e-06	9.72e-05	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	7.8e-06	9.58e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOA4—atherosclerosis	7.77e-06	9.55e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HMOX1—atherosclerosis	7.75e-06	9.52e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARG—atherosclerosis	7.74e-06	9.51e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	7.63e-06	9.38e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTHFR—atherosclerosis	7.62e-06	9.36e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SCARB1—atherosclerosis	7.6e-06	9.34e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—INS—atherosclerosis	7.59e-06	9.33e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—atherosclerosis	7.53e-06	9.26e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOB—atherosclerosis	7.42e-06	9.12e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PDGFB—atherosclerosis	7.41e-06	9.11e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTM1—atherosclerosis	7.22e-06	8.87e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HMGCR—atherosclerosis	7.18e-06	8.82e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOE—atherosclerosis	7.09e-06	8.71e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—LPL—atherosclerosis	7.08e-06	8.71e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.06e-06	8.67e-05	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	7.04e-06	8.65e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CAV1—atherosclerosis	7.03e-06	8.63e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOA1—atherosclerosis	7.01e-06	8.61e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ALB—atherosclerosis	6.96e-06	8.55e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GPX1—atherosclerosis	6.91e-06	8.49e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—atherosclerosis	6.81e-06	8.37e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NFKB1—atherosclerosis	6.74e-06	8.28e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CD36—atherosclerosis	6.73e-06	8.27e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	6.69e-06	8.22e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	6.69e-06	8.22e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOA2—atherosclerosis	6.69e-06	8.22e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALOX15—atherosclerosis	6.69e-06	8.22e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NOS3—atherosclerosis	6.66e-06	8.18e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK8—atherosclerosis	6.63e-06	8.14e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCG5—atherosclerosis	6.61e-06	8.12e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS2—atherosclerosis	6.61e-06	8.12e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ABCA1—atherosclerosis	6.4e-06	7.86e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LPA—atherosclerosis	6.38e-06	7.84e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MTHFR—atherosclerosis	6.38e-06	7.84e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARA—atherosclerosis	6.26e-06	7.69e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—BGN—atherosclerosis	6.18e-06	7.6e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOA5—atherosclerosis	6.12e-06	7.52e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—atherosclerosis	6.12e-06	7.52e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—atherosclerosis	6.09e-06	7.48e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AGT—atherosclerosis	6.06e-06	7.45e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—atherosclerosis	6.06e-06	7.44e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—INS—atherosclerosis	6.06e-06	7.44e-05	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—atherosclerosis	6e-06	7.38e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOE—atherosclerosis	5.94e-06	7.3e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.89e-06	7.24e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CAV1—atherosclerosis	5.88e-06	7.23e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOA1—atherosclerosis	5.87e-06	7.21e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK3—atherosclerosis	5.79e-06	7.11e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALOX5—atherosclerosis	5.69e-06	6.99e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—atherosclerosis	5.62e-06	6.9e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SERPINE1—atherosclerosis	5.56e-06	6.84e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HMOX1—atherosclerosis	5.49e-06	6.75e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CG—atherosclerosis	5.36e-06	6.59e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS3—atherosclerosis	5.31e-06	6.53e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOB—atherosclerosis	5.26e-06	6.46e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARG—atherosclerosis	5.17e-06	6.36e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MAPK3—atherosclerosis	5.15e-06	6.32e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTM1—atherosclerosis	5.12e-06	6.29e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.1e-06	6.27e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—INS—atherosclerosis	5.07e-06	6.23e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LIPC—atherosclerosis	5.07e-06	6.23e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOC3—atherosclerosis	5.04e-06	6.19e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LPL—atherosclerosis	5.02e-06	6.17e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LDLR—atherosclerosis	5.01e-06	6.15e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GPX1—atherosclerosis	4.9e-06	6.02e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CETP—atherosclerosis	4.89e-06	6.01e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CD36—atherosclerosis	4.77e-06	5.86e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.68e-06	5.76e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALB—atherosclerosis	4.65e-06	5.72e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTHFR—atherosclerosis	4.52e-06	5.56e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NOS3—atherosclerosis	4.45e-06	5.47e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARA—atherosclerosis	4.44e-06	5.45e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.42e-06	5.44e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AGT—atherosclerosis	4.3e-06	5.28e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—atherosclerosis	4.23e-06	5.2e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOE—atherosclerosis	4.21e-06	5.17e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CAV1—atherosclerosis	4.17e-06	5.13e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOA1—atherosclerosis	4.16e-06	5.11e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.94e-06	4.85e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—atherosclerosis	3.9e-06	4.8e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.8e-06	4.67e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—atherosclerosis	3.79e-06	4.66e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARG—atherosclerosis	3.67e-06	4.51e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK3—atherosclerosis	3.62e-06	4.45e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—INS—atherosclerosis	3.6e-06	4.42e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—atherosclerosis	3.51e-06	4.32e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—atherosclerosis	3.47e-06	4.26e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.38e-06	4.16e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALB—atherosclerosis	3.3e-06	4.05e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOB—atherosclerosis	3.24e-06	3.98e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NOS3—atherosclerosis	3.15e-06	3.88e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.15e-06	3.87e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LPL—atherosclerosis	3.09e-06	3.8e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—atherosclerosis	3.06e-06	3.76e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GPX1—atherosclerosis	3.02e-06	3.71e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CD36—atherosclerosis	2.94e-06	3.61e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—atherosclerosis	2.88e-06	3.54e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.79e-06	3.42e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARA—atherosclerosis	2.73e-06	3.36e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AGT—atherosclerosis	2.65e-06	3.25e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—atherosclerosis	2.65e-06	3.25e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOE—atherosclerosis	2.59e-06	3.19e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CAV1—atherosclerosis	2.57e-06	3.16e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOA1—atherosclerosis	2.56e-06	3.15e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—atherosclerosis	2.44e-06	3e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.34e-06	2.88e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARG—atherosclerosis	2.26e-06	2.78e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—INS—atherosclerosis	2.22e-06	2.72e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—atherosclerosis	2.05e-06	2.51e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALB—atherosclerosis	2.03e-06	2.5e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NOS3—atherosclerosis	1.94e-06	2.39e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.78e-06	2.18e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—atherosclerosis	1.45e-06	1.78e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—atherosclerosis	8.93e-07	1.1e-05	CbGpPWpGaD
